Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism.

Hakan GüneşHandan GunesMusa DagliMehmet KirişçiMeryem ÖzbekNurhan AtillaMehmet Birhan Yılmaz

Published in: Arquivos brasileiros de cardiologia (2024)

Soluble ST2 level seems to be a biomarker to predict 6-month mortality and/or recurrent Cardiovascular-Related hospitalization in patients with acute PE.

Keyphrases

pulmonary embolism
cardiovascular events
inferior vena cava
risk factors
cardiovascular disease
type diabetes
coronary artery disease
drug induced